montelukast
Appearance
English
[edit]Etymology
[edit]From Mont(r)e(al) + -lukast (“leukotriene receptor antagonist”), named after the city of Montreal, where the drug was developed by Merck in 1991.
Pronunciation
[edit]- (General American) IPA(key): /ˌmɑn.təˈluːˌkæst/
Noun
[edit]montelukast (uncountable)
- (pharmacology) A leukotriene antagonist (trademark Singulair) used orally in the form of its sodium salt C35H35ClNNaO3S to treat asthma or to relieve the symptoms of seasonal allergic rhinitis.
Translations
[edit]leukotriene receptor antagonist
References
[edit]- “montelukast”, in Merriam-Webster Online Dictionary, Springfield, Mass.: Merriam-Webster, 1996–present.
Spanish
[edit]Noun
[edit]montelukast m (plural montelukasts)